Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

This study has been completed.
Aalborg Universitetshospital
Information provided by:
Pronova BioPharma Identifier:
First received: February 23, 2006
Last updated: March 10, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)